- The Future of Cancer Diagnostics:How advanced molecular techniques, specialized fluorescence applications, and re-establishment of tumor microenvironments within a lab setting are paving the way for personalized medicine. An overview of past and current cancer diagnostics techniques as well as new research by Dr. Danny Enepekides and members of the Lattice Biologics team.
- $1.37 Million Update for Lattice’s Merger with Blackstone Ventures:Read the latest press release regarding our reverse merger process, featuring another infusion of capital from Blackstone.
- Welcome to Dr. Enepekides:Get to know the newest member of our Scientific Advisory Board,Dr. Danny Enepekides, BSc, MDCM, MPH, FRCSC, the Chief of Surgical Oncology for the second largest Cancer Centre in Canada and Associate Professor of Otolaryngology – Head and Neck Surgery at the University of Toronto whose research is featured in this issue’s Cancer Diagnostics article.
- Biologics Fun Fact: Sour Grapes – From Promises of Cancer Cures to Chemical Compounds – Why We All Love Wine:As a follow-up to last issue’s fun fact about stinky cheese, we felt it was only fair to give our fellow oenophiles their day in the sun, too. What is the truth behind all the health talk? Where do all those flavor nuances really come from? Lattice Biologics separates the scientific truth of wine’s wellness wonders from wishful thinking.
Read the complete newsletter here. Click Subscribe to receive updates. ______ Media Contact: Melanie Battista, Public Relations, Lattice Biologics Inc., 16701 N 90th Street, Suite #101, Scottsdale, AZ 85260, 480-563-0800 Office, News@LatticeBiologics.com | www.LatticeBiologics.com Subscribe to Lattice News Updates Follow us on Twitter: @LatticeBio